Biotechnology startup

Quratis

Quratis develops vaccines and cell therapies for tuberculosis.

Funding reportedLast round: Private equity

Biotechnology

What company datasets say Quratis raised

Funding, as reported

Reported in all42.7Bin the source's currency
Rounds2
Last roundPrivate equity
Last round dateSept 2021
Investors listed2

On a portfolio page

Investors who name them

Each firm lists Quratis on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Quratis in front of investors. Or tell us what we have wrong.

List your startupSend a correction